Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) – USD ($)
 3 Months Ended 9 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Apr. 30, 2022
Apr. 30, 2021
Income Statement [Abstract]        
Revenue        
Expenses:        
Research and development 7,030,607  7,589,779  20,501,917  26,304,520 
General and administrative 2,517,105  2,847,151  8,377,722  8,198,580 
Loss from operations (9,547,712)  (10,436,930)  (28,879,639)  (34,503,100) 
Gain on extinguishment of debt   960,790    960,790 
Other income (expense), net 2,182  1,723  (2,412)  660 
Interest expense (2,701)  (1,732)  (16,128)  (12,587) 
Foreign currency exchange gain (loss), net (36,191)  35,365  (399,338)  187,039 
Loss before income taxes (9,584,422)  (9,440,784)  (29,297,517)  (33,367,198) 
Income tax (benefit) expense (3,337,117)  1,542  (3,334,167)  4,492 
Net loss $ (6,247,305)  $ (9,442,326)  $ (25,963,350)  $ (33,371,690) 
Basic and diluted net loss per common share $ (0.16)  $ (0.25)  $ (0.66)  $ (1.08) 
Weighted average shares used in computing basic and diluted net loss per common share 39,355,672  37,335,563  39,281,841  30,857,405